Insights Archives

The difference between aseptic processing and terminal sterilization

Both aseptic processing and terminal sterilization remove contamination from drug products, but the two methods are not the same, and they are not interchangeable.

The digital age of design, construction, and manufacturing

Digital delivery, digital twins, and industrialized construction are shaking up construction and manufacturing. Here’s what you need to know about how these innovative technologies are being applied to lower costs and speed up schedules.

Planning sustainable building designs with sustainability charrettes

Leveraging a sustainability charrette in early building sustainability planning maximizes the opportunities to conserve resources, enhance resiliency, and reduce operating costs while being mindful of the project’s overall timeline and budget.

Interior design for life sciences environments

Where science, creativity, and business are seamless.

Industry 4.0 technology with smart manufacturing icons

4 ways to reduce costs with Industry 4.0

For life sciences companies, Industry 4.0 offers a path to make manufacturing facilities more efficient.

steam system inside a food manufacturing plant

How to reduce food manufacturing cost through energy efficiency

The equation is simple: cut energy consumption and costs go down. The question for many food and beverage manufacturers is, what specifically to do and where to start?

person on tablet controlling automation system

An introduction to control systems integration

Control systems integration is a plant management strategy that harmonizes operations across different processes and systems, ensuring a secure and seamless flow of operational data.

6 questions to ask before transitioning to commercial-scale ATMP manufacturing

To move advanced therapy medicinal products (ATMPs) from the lab to the commercial-scale manufacturing facility, you need a future-proof plan. These 6 questions will help you create one.

How to achieve a viral vector manufacturing facility at scale

For viral vectors to mature into a commercially successful submarket that’s accessible to patients, manufacturers need novel solutions and facilities designed for flexibility, scalability, and long-term innovation.